[Properties of erythrocyte phosphofructokinase in normal humans].
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000494:Allosteric Regulation; D000645:Ammonium Sulfate; D001665:Binding Sites; D011232:Chemical Precipitation; D002848:Chromatography, DEAE-Cellulose; D002951:Citrates / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D004163:Diphosphoglyceric Acids / Q000494:pharmacology; D004789:Enzyme Activation; D004912:Erythrocytes / Q000201:enzymology*; D005636:Fructosephosphates / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008024:Ligands; D008274:Magnesium / Q000494:pharmacology; D010732:Phosphofructokinase-1 / Q000037:antagonists & inhibitors / Q000097:blood* / Q000302:isolation & purification / Q000378:metabolism
D002951:Citrates; D004163:Diphosphoglyceric Acids; D005636:Fructosephosphates; D008024:Ligands; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D010732:Phosphofructokinase-1; D008274:Magnesium; D000645:Ammonium Sulfate
Etude de quelques propriétés de la phosphofructokinase érythrocytaire de l'homme normal.